Keywords
Last Name

Marshall Kadin, MD

TitleProfessor
InstitutionBoston University School of Medicine
DepartmentDermatology
Phone(401) 456-2000
Other Positions
InstitutionRoger Williams Medical Center

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Mar 23. PMID: 28337783.
    View in: PubMed
  2. Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Expression of p63 protein in anaplastic large cell lymphoma: Implications for genetic subtyping. Hum Pathol. 2017 Jan 30. PMID: 28153507.
    View in: PubMed
  3. Watanabe M, Nakano K, Kadin ME, Higashihara M, Watanabe T, Horie R. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells. Am J Pathol. 2017 Jan; 187(1):163-175. PMID: 27870927.
    View in: PubMed
  4. Battistella M, Janin A, Jean-Louis F, Collomb C, Leboeuf C, Sicard H, Bonnafous C, Dujardin A, Ram-Wolff C, Kadin ME, Bensussan A, Bagot M, Michel L. KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol. 2016 Aug; 175(2):325-33. PMID: 27037558.
    View in: PubMed
  5. Ehrentraut S, Schneider B, Nagel S, Pommerenke C, Quentmeier H, Geffers R, Feist M, Kaufmann M, Meyer C, Kadin ME, Drexler HG, MacLeod RA. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. Oncotarget. 2016 Jun 07; 7(23):34201-16. PMID: 27144517.
    View in: PubMed
  6. Hu H, Johani K, Almatroudi A, Vickery K, Van Natta B, Kadin ME, Brody G, Clemens M, Cheah CY, Lade S, Joshi PA, Prince HM, Deva AK. Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016 Jun; 137(6):1659-69. PMID: 26890506.
    View in: PubMed
  7. Andrique L, Poglio S, Prochazkova-Carlotti M, Kadin ME, Giese A, Idrissi Y, Beylot-Barry M, Merlio JP, Chevret E. Intrahepatic Xenograft of Cutaneous T-Cell Lymphoma Cell Lines: A Useful Model for Rapid Biological and Therapeutic Evaluation. Am J Pathol. 2016 Jul; 186(7):1775-85. PMID: 27181405.
    View in: PubMed
  8. Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, Van Natta BW, Adams WP, Brody GS, Epstein AL. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016 Jul; 36(7):773-81. PMID: 26979456.
    View in: PubMed
  9. Vonderheid EC, Kadin ME, Telang GH. Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences. J Cutan Pathol. 2016 Apr; 43(4):303-12. PMID: 26566599.
    View in: PubMed
  10. Toda T, Watanabe M, Kawato J, Kadin ME, Higashihara M, Kunisada T, Umezawa K, Horie R. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines. Br J Haematol. 2015 Sep; 170(6):837-46. PMID: 26105086.
    View in: PubMed
  11. Kadin ME. CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right. Br J Dermatol. 2015 Jun; 172(6):1478-9. PMID: 26036155.
    View in: PubMed
  12. Guitart J, Martinez-Escala ME, Deonizio JM, Gerami P, Kadin ME. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes. J Am Acad Dermatol. 2015 Mar; 72(3):508-15. PMID: 25582534.
    View in: PubMed
  13. Martinez-Escala ME, Sidiropoulos M, Deonizio J, Gerami P, Kadin ME, Guitart J. ?d T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous ?d T-cell lymphomas. Br J Dermatol. 2015 Feb; 172(2):372-9. PMID: 25143223.
    View in: PubMed
  14. Wolk K, Mitsui H, Witte K, Gellrich S, Gulati N, Humme D, Witte E, Gonsior M, Beyer M, Kadin ME, Volk HD, Krueger JG, Sterry W, Sabat R. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clin Cancer Res. 2014 Nov 1; 20(21):5507-16. PMID: 25212608.
    View in: PubMed
  15. Wang SS, Flowers CR, Kadin ME, Chang ET, Hughes AM, Ansell SM, Feldman AL, Lightfoot T, Boffetta P, Melbye M, Lan Q, Sampson JN, Morton LM, Zhang Y, Weisenburger DD. Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):66-75. PMID: 25174027.
    View in: PubMed
  16. Aschebrook-Kilfoy B, Cocco P, La Vecchia C, Chang ET, Vajdic CM, Kadin ME, Spinelli JJ, Morton LM, Kane EV, Sampson JN, Kasten C, Feldman AL, Wang SS, Zhang Y. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):98-105. PMID: 25174030.
    View in: PubMed
  17. Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):130-44. PMID: 25174034.
    View in: PubMed
  18. Morton LM, Sampson JN, Cerhan JR, Turner JJ, Vajdic CM, Wang SS, Smedby KE, de Sanjosé S, Monnereau A, Benavente Y, Bracci PM, Chiu BC, Skibola CF, Zhang Y, Mbulaiteye SM, Spriggs M, Robinson D, Norman AD, Kane EV, Spinelli JJ, Kelly JL, La Vecchia C, Dal Maso L, Maynadié M, Kadin ME, Cocco P, Costantini AS, Clarke CA, Roman E, Miligi L, Colt JS, Berndt SI, Mannetje A, de Roos AJ, Kricker A, Nieters A, Franceschi S, Melbye M, Boffetta P, Clavel J, Linet MS, Weisenburger DD, Slager SL. Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014 Aug; 2014(48):1-14. PMID: 25174022.
    View in: PubMed
  19. Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, Wittig BM, Warszawska K, Kurek A, Erdmann-Keding M, Kunz S, Asadullah K, Kadin ME, Volk HD, Sterry W, Wolk K, Sabat R. IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol. 2014 Nov; 134(11):2757-67. PMID: 25046339.
    View in: PubMed
  20. Wang Y, Gu X, Zhang G, Wang L, Wang T, Zhao Y, Zhang X, Zhou Y, Kadin M, Tu P. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21. Blood. 2014 May 29; 123(22):3452-61. PMID: 24747435.
    View in: PubMed
  21. Kadin ME, Hughey LC, Wood GS. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium. J Am Acad Dermatol. 2014 Feb; 70(2):374-6. PMID: 24438952.
    View in: PubMed
  22. Karai LJ, Kadin ME, Hsi ED, Sluzevich JC, Ketterling RP, Knudson RA, Feldman AL. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol. 2013 Aug; 37(8):1173-81. PMID: 23648461.
    View in: PubMed
  23. Vonderheid EC, Pavlov I, Delgado JC, Martins TB, Telang GH, Hess AD, Kadin ME. Prognostic factors and risk stratification in early mycosis fungoides. Leuk Lymphoma. 2014 Jan; 55(1):44-50. PMID: 23547839.
    View in: PubMed
  24. Ehrentraut S, Nagel S, Scherr ME, Schneider B, Quentmeier H, Geffers R, Kaufmann M, Meyer C, Prochorec-Sobieszek M, Ketterling RP, Knudson RA, Feldman AL, Kadin ME, Drexler HG, MacLeod RA. t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5. PLoS One. 2013; 8(1):e53767. PMID: 23372669.
    View in: PubMed
  25. Csikesz CR, Knudson RA, Greipp PT, Feldman AL, Kadin M. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22. J Invest Dermatol. 2013 Jun; 133(6):1680-2. PMID: 23337887.
    View in: PubMed
  26. Vasmatzis G, Johnson SH, Knudson RA, Ketterling RP, Braggio E, Fonseca R, Viswanatha DS, Law ME, Kip NS, Ozsan N, Grebe SK, Frederick LA, Eckloff BW, Thompson EA, Kadin ME, Milosevic D, Porcher JC, Asmann YW, Smith DI, Kovtun IV, Ansell SM, Dogan A, Feldman AL. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood. 2012 Sep 13; 120(11):2280-9. PMID: 22855598.
    View in: PubMed
  27. Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, Sposto R, Kadin ME, Hutchinson RJ, Nachman J. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group. J Clin Oncol. 2012 Sep 10; 30(26):3174-80. PMID: 22649136.
    View in: PubMed
  28. Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol. 2011 Dec; 33(8):835-40. PMID: 22042257.
    View in: PubMed
  29. Watanabe M, Itoh K, Togano T, Kadin ME, Watanabe T, Higashihara M, Horie R. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma. Am J Pathol. 2012 Feb; 180(2):831-8. PMID: 22107829.
    View in: PubMed
  30. Kadin ME, Pavlov IY, Delgado JC, Vonderheid EC. High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides. J Invest Dermatol. 2012 Mar; 132(3 Pt 1):703-10. PMID: 22071475.
    View in: PubMed
  31. Watanabe M, Nakano K, Togano T, Nakashima M, Higashihara M, Kadin ME, Watanabe T, Horie R. Targeted repression of overexpressed CD30 downregulates NF-kappaB and ERK1/2 pathway in Hodgkin lymphoma cell lines. Oncol Res. 2011; 19(10-11):463-9. PMID: 22715589.
    View in: PubMed
  32. Rathore B, Kadin ME. Hodgkin's lymphoma therapy: past, present, and future. Expert Opin Pharmacother. 2010 Dec; 11(17):2891-906. PMID: 21050034.
    View in: PubMed
  33. Hirsch B, Braun FK, Al-Yacoub N, Assaf C, Kadin ME, Sterry W, Eberle J, Dürkop H. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells]. Pathologe. 2010 Oct; 31 Suppl 2:193-8. PMID: 20812013.
    View in: PubMed
  34. Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadié M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010 Nov 18; 116(20):e90-8. PMID: 20699439.
    View in: PubMed
  35. Kadin ME, Vonderheid EC. Targeted therapies: Denileukin diftitox--a step towards a 'magic bullet' for CTCL. Nat Rev Clin Oncol. 2010 Aug; 7(8):430-2. PMID: 20668480.
    View in: PubMed
  36. Kadin ME. Macrophages in Hodgkin's lymphoma. N Engl J Med. 2010 Jun 3; 362(22):2135-6; author reply 2136. PMID: 20527059.
    View in: PubMed
  37. Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. Appl Immunohistochem Mol Morphol. 2010 Jan; 18(1):16-23. PMID: 19550297.
    View in: PubMed
  38. Kadin ME. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders. Oncology (Williston Park). 2009 Nov 30; 23(13):1158-64. PMID: 20043465.
    View in: PubMed
  39. Braun FK, Hirsch B, Al-Yacoub N, Dürkop H, Assaf C, Kadin ME, Sterry W, Eberle J. Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP. J Invest Dermatol. 2010 Mar; 130(3):826-40. PMID: 19890350.
    View in: PubMed
  40. Mathas S, Kreher S, Meaburn KJ, Jöhrens K, Lamprecht B, Assaf C, Sterry W, Kadin ME, Daibata M, Joos S, Hummel M, Stein H, Janz M, Anagnostopoulos I, Schrock E, Misteli T, Dörken B. Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A. 2009 Apr 7; 106(14):5831-6. PMID: 19321746.
    View in: PubMed
  41. Kilbridge TM, Kadin ME. Teenager with hairy cell leukemia: 30-year follow-up. J Clin Oncol. 2009 Jan 1; 27(1):155-6. PMID: 19047276.
    View in: PubMed
  42. Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Am J Surg Pathol. 2008 Sep; 32(9):1421-6. PMID: 18670345.
    View in: PubMed
  43. Fantin VR, Loboda A, Paweletz CP, Hendrickson RC, Pierce JW, Roth JA, Li L, Gooden F, Korenchuk S, Hou XS, Harrington EA, Randolph S, Reilly JF, Ware CM, Kadin ME, Frankel SR, Richon VM. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma. Cancer Res. 2008 May 15; 68(10):3785-94. PMID: 18483262.
    View in: PubMed
  44. Rosenwald IB, Koifman L, Savas L, Chen JJ, Woda BA, Kadin ME. Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum Pathol. 2008 Jun; 39(6):910-6. PMID: 18234281.
    View in: PubMed
  45. Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T, Okayasu I, Higashihara M, Horie R. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest. 2008 Jan; 88(1):48-57. PMID: 17965727.
    View in: PubMed
  46. Staber PB, Vesely P, Haq N, Ott RG, Funato K, Bambach I, Fuchs C, Schauer S, Linkesch W, Hrzenjak A, Dirks WG, Sexl V, Bergler H, Kadin ME, Sternberg DW, Kenner L, Hoefler G. The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood. 2007 Nov 1; 110(9):3374-83. PMID: 17690253.
    View in: PubMed
  47. Droc C, Cualing HD, Kadin ME. Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin. Cancer Control. 2007 Apr; 14(2):124-32. PMID: 17387297.
    View in: PubMed
  48. Watanabe M, Dewan MZ, Taira M, Shoda M, Honda M, Sata T, Higashihara M, Kadin ME, Watanabe T, Yamamoto N, Umezawa K, Horie R. IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells. Lab Invest. 2007 Apr; 87(4):372-82. PMID: 17310217.
    View in: PubMed
  49. Lones MA, Heerema NA, Le Beau MM, Sposto R, Perkins SL, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Buckley J, Abromowitch M, Kersey J, Bergeron S, Cairo MS, Sanger WG. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet. 2007 Jan 1; 172(1):1-11. PMID: 17175373.
    View in: PubMed
  50. Lones MA, Heerema NA, Le Beau MM, Perkins SL, Kadin ME, Kjeldsberg CR, Sposto R, Meadows A, Siegel S, Buckley J, Finlay J, Abromowitch M, Cairo MS, Sanger WG. Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet Cytogenet. 2006 Dec; 171(2):89-96. PMID: 17116485.
    View in: PubMed
  51. Vonderheid EC, Kadin ME. Papular mycosis fungoides: a variant of mycosis fungoides or lymphomatoid papulosis? J Am Acad Dermatol. 2006 Jul; 55(1):177-80. PMID: 16781328.
    View in: PubMed
  52. Kadin ME. Pathobiology of CD30+ cutaneous T-cell lymphomas. J Cutan Pathol. 2006 Feb; 33 Suppl 1:10-7. PMID: 16412208.
    View in: PubMed
  53. Watanabe M, Sasaki M, Itoh K, Higashihara M, Umezawa K, Kadin ME, Abraham LJ, Watanabe T, Horie R. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. Cancer Res. 2005 Sep 1; 65(17):7628-34. PMID: 16140928.
    View in: PubMed
  54. Nachman J, Sposto R, Herzog P, Wolden S, Kadin M. Low dose involved field radiation (IFRT) or no further treatment following complete response to initial chemotherapy in young adult (YA) patients 16-21 years of age with Hodgkin's disease (HD): The Children's Cancer Group (CCG) Experience. J Clin Oncol. 2005 Jun; 23(16_suppl):8513. PMID: 27944597.
    View in: PubMed
  55. Franchina M, Kadin ME, Abraham LJ. Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1322-5. PMID: 15894695.
    View in: PubMed
  56. Greisser J, Doebbeling U, Roos M, Mueller B, Schmid M, Burg G, Kadin ME, Kempf W. Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol. 2005 May; 14(5):380-5. PMID: 15854132.
    View in: PubMed
  57. Adams AE, Zwicker J, Curiel C, Kadin ME, Falchuk KR, Drews R, Kupper TS. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. J Am Acad Dermatol. 2004 Oct; 51(4):660-2. PMID: 15389210.
    View in: PubMed
  58. Rübben A, Kempf W, Kadin ME, Zimmermann DR, Burg G. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol. 2004 Aug; 13(8):472-83. PMID: 15265011.
    View in: PubMed
  59. Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME, Watanabe T. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma. Cancer Cell. 2004 Apr; 5(4):353-64. PMID: 15093542.
    View in: PubMed
  60. Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. Arch Dermatol. 2004 Mar; 140(3):306-12. PMID: 15023774.
    View in: PubMed
  61. Lones MA, Sanger WG, Le Beau MM, Heerema NA, Sposto R, Perkins SL, Buckley J, Kadin ME, Kjeldsberg CR, Meadows A, Siegel S, Finlay J, Bergeron S, Cairo MS. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08. J Pediatr Hematol Oncol. 2004 Mar; 26(3):169-78. PMID: 15125609.
    View in: PubMed
  62. Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, Knaus P, Kadin ME. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor. Cancer Detect Prev. 2004; 28(1):57-64. PMID: 15041079.
    View in: PubMed
  63. Dereure O, Levi E, Vonderheid EC, Kadin ME. Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis. Arch Dermatol. 2003 Dec; 139(12):1571-5. PMID: 14676072.
    View in: PubMed
  64. Younes A, Kadin ME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol. 2003 Sep 15; 21(18):3526-34. PMID: 12972530.
    View in: PubMed
  65. Watanabe M, Ogawa Y, Ito K, Higashihara M, Kadin ME, Abraham LJ, Watanabe T, Horie R. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am J Pathol. 2003 Aug; 163(2):633-41. PMID: 12875982.
    View in: PubMed
  66. Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol. 2003 Jul; 40(3):244-56. PMID: 12876673.
    View in: PubMed
  67. Willers J, Dummer R, Kempf W, Kündig T, Burg G, Kadin ME. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res. 2003 Jul; 9(7):2744-54. PMID: 12855655.
    View in: PubMed
  68. Kadin ME. Genetic and molecular genetic studies in the diagnosis of T-cell malignancies. Hum Pathol. 2003 Apr; 34(4):322-9. PMID: 12733110.
    View in: PubMed
  69. Kadin ME. Proceedings of the Boston workshop on cytogenetics and molecular genetics of hematologic malignancies, November 8 to 11, 2001: introduction. Hum Pathol. 2003 Apr; 34(4):305. PMID: 12733107.
    View in: PubMed
  70. Burg G, Kempf W, Kazakov DV, Dummer R, Frosch PJ, Lange-Ionescu S, Nishikawa T, Kadin ME. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol. 2003 Mar; 148(3):580-6. PMID: 12653754.
    View in: PubMed
  71. Kempf W, Kadin ME, Dvorak AM, Lord CC, Burg G, Letvin NL, Koralnik IJ. Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis. 2003 Feb; 24(2):301-6. PMID: 12584181.
    View in: PubMed
  72. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Müller-Hermelink HK, Paulli M, Wechsler J, Willemze R, Audring H, Bernengo MG, Cerroni L, Chimenti S, Chott A, Díaz-Pérez JL, Dippel E, Duncan LM, Feller AC, Geerts ML, Hallermann C, Kempf W, Russell-Jones R, Sander C, Berti E. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003 Feb 1; 97(3):610-27. PMID: 12548603.
    View in: PubMed
  73. Cairo MS, Sposto R, Perkins SL, Meadows AT, Hoover-Regan ML, Anderson JR, Siegel SE, Lones MA, Tedeschi-Blok N, Kadin ME, Kjeldsberg CR, Wilson JF, Sanger W, Morris E, Krailo MD, Finlay JL. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003 Feb; 120(4):660-70. PMID: 12588354.
    View in: PubMed
  74. Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE, Kadin ME, Kjeldsberg CR, Wilson JF, Perkins SL, Lones MA, Morris E, Finlay JL. Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol. 2003 Jan; 72(1):53-63. PMID: 12508269.
    View in: PubMed
  75. Kleinhans M, Tun-Kyi A, Gilliet M, Kadin ME, Dummer R, Burg G, Nestle FO. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood. 2003 Feb 15; 101(4):1487-93. PMID: 12393570.
    View in: PubMed
  76. Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol. 2002 Sep 15; 20(18):3765-71. PMID: 12228196.
    View in: PubMed
  77. Willenbrock K, Ichinohasama R, Kadin ME, Miura I, Terui T, Meguro K, Fukuhara O, DeCoteau JF, Hansmann ML. T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction. Lab Invest. 2002 Sep; 82(9):1103-9. PMID: 12218070.
    View in: PubMed
  78. Kadin ME. T-cell clonality in pityriasis lichenoides: evidence for a premalignant or reactive immune disorder? Arch Dermatol. 2002 Aug; 138(8):1089-90. PMID: 12164749.
    View in: PubMed
  79. Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol. 2002 Jun; 118(6):949-56. PMID: 12060388.
    View in: PubMed
  80. Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, Burg G, Kadin ME. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol. 2002 May; 29(5):295-300. PMID: 12100631.
    View in: PubMed
  81. Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL, Cairo MS. Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol. 2002 May 1; 20(9):2293-301. PMID: 11981000.
    View in: PubMed
  82. Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M, Watanabe T. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol. 2002 May; 160(5):1647-54. PMID: 12000717.
    View in: PubMed
  83. Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, Watanabe T. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene. 2002 Apr 11; 21(16):2493-503. PMID: 11971184.
    View in: PubMed
  84. Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR, Kadin ME, Radel E, Steinherz LJ, Morris E, Finlay JL, Meadows AT. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002 Apr; 16(4):594-600. PMID: 11960338.
    View in: PubMed
  85. Kadin ME, Drews R, Samel A, Gilchrist A, Kocher O. Hodgkin's lymphoma of T-cell type: clonal association with a CD30+ cutaneous lymphoma. Hum Pathol. 2001 Nov; 32(11):1269-72. PMID: 11727269.
    View in: PubMed
  86. Sposto R, Meadows AT, Chilcote RR, Steinherz PG, Kjeldsberg C, Kadin ME, Krailo MD, Termuhlen AM, Morse M, Siegel SE. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov; 37(5):432-41. PMID: 11745871.
    View in: PubMed
  87. Zhu D, Kadin ME, Samoszuk M. Detection of clonal T-cell receptor-gamma gene rearrangement by PCR/temporal temperature gradient gel electrophoresis. Am J Clin Pathol. 2001 Oct; 116(4):527-34. PMID: 11601137.
    View in: PubMed
  88. Levi E, Pfeifer WM, Kadin ME. CD30-activation-mediated growth inhibition of anaplastic large-cell lymphoma cell lines: apoptosis or cell-cycle arrest? Blood. 2001 Sep 1; 98(5):1630-2. PMID: 11547770.
    View in: PubMed
  89. Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. Ann N Y Acad Sci. 2001 Sep; 941:59-68. PMID: 11594583.
    View in: PubMed
  90. Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001 Jul; 137(7):949-52. PMID: 11453817.
    View in: PubMed
  91. Pantanowitz L, Saldinger PF, Kadin ME. Pathologic quiz case: Hepatic mass in a patient with renal cell carcinoma. Arch Pathol Lab Med. 2001 Apr; 125(4):577-8. PMID: 11260645.
    View in: PubMed
  92. Li S, Ross DT, Kadin ME, Brown PO, Wasik MA. Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray. Am J Pathol. 2001 Apr; 158(4):1231-7. PMID: 11290540.
    View in: PubMed
  93. Kempf W, Kadin ME, Kutzner H, Lord CL, Burg G, Letvin NL, Koralnik IJ. Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol. 2001 Jan; 28(1):29-33. PMID: 11168749.
    View in: PubMed
  94. Dereure O, Levi E, Kadin ME. T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000 Dec; 136(12):1483-6. PMID: 11115158.
    View in: PubMed
  95. Levi E, Wang Z, Petrogiannis-Haliotis T, Pfeifer WM, Kempf W, Drews R, Kadin ME. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression. J Invest Dermatol. 2000 Dec; 115(6):1034-40. PMID: 11121138.
    View in: PubMed
  96. Kempf W, Margolin DH, Dezube BJ, Kadin ME, Letvin NL, Koralnik IJ. Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol. 2000 Dec; 65(4):302-6. PMID: 11074559.
    View in: PubMed
  97. Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S, Robison LL. Pesticide exposures in children with non-Hodgkin lymphoma. Cancer. 2000 Dec 1; 89(11):2315-21. PMID: 11147603.
    View in: PubMed
  98. Lones MA, Perkins SL, Sposto R, Kadin ME, Kjeldsberg CR, Wilson JF, Cairo MS. Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol. 2000 Nov 15; 18(22):3845-53. PMID: 11078498.
    View in: PubMed
  99. Kadin ME. Cutaneous gamma delta T-cell lymphomas--how and why should they be recognized? Arch Dermatol. 2000 Aug; 136(8):1052-4. PMID: 10926743.
    View in: PubMed
  100. Drews R, Samel A, Kadin ME. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. Semin Cutan Med Surg. 2000 Jun; 19(2):109-17. PMID: 10892712.
    View in: PubMed
  101. Murphy M, Signoretti S, Kadin ME, Loda M. Detection of TCR-gamma gene rearrangements in early mycosis fungoides by non-radioactive PCR-SSCP. J Cutan Pathol. 2000 May; 27(5):228-34. PMID: 10847547.
    View in: PubMed
  102. Kadin ME. Regulation of CD30 antigen expression and its potential significance for human disease. Am J Pathol. 2000 May; 156(5):1479-84. PMID: 10793058.
    View in: PubMed
  103. Lowsky R, Magliocco A, Ichinohasama R, Reitmair A, Scott S, Henry M, Kadin ME, DeCoteau JF. MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. Blood. 2000 Mar 1; 95(5):1767-72. PMID: 10688836.
    View in: PubMed
  104. Przybylski GK, Wu H, Macon WR, Finan J, Leonard DG, Felgar RE, DiGiuseppe JA, Nowell PC, Swerdlow SH, Kadin ME, Wasik MA, Salhany KE. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn. 2000 Feb; 2(1):11-9. PMID: 11272897.
    View in: PubMed
  105. Ichinohasama R, Miura I, Takahashi N, Sugawara T, Tamate E, Endoh K, Endoh F, Naganuma H, DeCoteau JF, Griffin JD, Kadin ME, Ooya K. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia. 2000 Jan; 14(1):169-82. PMID: 10637493.
    View in: PubMed
  106. Signoretti S, Murphy M, Puddu P, DeCoteau JF, Faraggiana T, Kadin ME, Loda M. Clonality of cutaneous B-cell infiltrates determined by microdissection and immunoglobulin gene rearrangement. Diagn Mol Pathol. 1999 Dec; 8(4):176-82. PMID: 10617273.
    View in: PubMed
  107. Mori M, Manuelli C, Pimpinelli N, Mavilia C, Maggi E, Santucci M, Bianchi B, Cappugi P, Giannotti B, Kadin ME. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression. Blood. 1999 Nov 1; 94(9):3077-83. PMID: 10556192.
    View in: PubMed
  108. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood. 1999 Oct 15; 94(8):2854-61. PMID: 10515889.
    View in: PubMed
  109. Wang HH, Myers T, Lach LJ, Hsieh CC, Kadin ME. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. Cancer. 1999 Oct 1; 86(7):1240-5. PMID: 10506709.
    View in: PubMed
  110. Pfeifer W, Levi E, Petrogiannis-Haliotis T, Lehmann L, Wang Z, Kadin ME. A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1). Am J Pathol. 1999 Oct; 155(4):1353-9. PMID: 10514417.
    View in: PubMed
  111. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Suzumiya J, Go JH. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma. Hum Pathol. 1999 Apr; 30(4):403-11. PMID: 10208461.
    View in: PubMed
  112. Signoretti S, Murphy M, Cangi MG, Puddu P, Kadin ME, Loda M. Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol. 1999 Jan; 154(1):67-75. PMID: 9916920.
    View in: PubMed
  113. Kinney MC, Kadin ME. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation. Am J Clin Pathol. 1999 Jan; 111(1 Suppl 1):S56-67. PMID: 9894470.
    View in: PubMed
  114. Hodges KB, Collins RD, Greer JP, Kadin ME, Kinney MC. Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features. Am J Surg Pathol. 1999 Jan; 23(1):49-58. PMID: 9888703.
    View in: PubMed
  115. Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998 Dec; 22(12):1528-37. PMID: 9850179.
    View in: PubMed
  116. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev. 1998 Dec; 7(12):1117-21. PMID: 9865430.
    View in: PubMed
  117. Paulli M, Berti E, Boveri E, Kindl S, Bonoldi E, Gambini C, Rosso R, Borroni G, Straccapansa V, Magrini U, DeCoteau JE, Krammer PH, Möller P, Kadin ME. Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily. Hum Pathol. 1998 Nov; 29(11):1223-30. PMID: 9824099.
    View in: PubMed
  118. Bhattacharyya N, Frankenthaler RA, Gomolin HI, Kadin ME, Lauretano AM. Clinical and pathologic characterization of mucosa-associated lymphoid tissue lymphoma of the head and neck. Ann Otol Rhinol Laryngol. 1998 Sep; 107(9 Pt 1):801-6. PMID: 9749552.
    View in: PubMed
  119. Ichinohasama R, Miura I, Funato T, Sato I, Suzuki C, Saito Y, Decoteau JF, Myers JB, Kadin ME, Sawai T, Ooya K. A recurrent nonrandom translocation (3;7)(q27;p12) associated with BCL-6 gene rearrangement in B-cell diffuse large cell lymphoma. Cancer Genet Cytogenet. 1998 Jul 1; 104(1):19-27. PMID: 9648553.
    View in: PubMed
  120. Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer. 1998 Jun; 22(2):114-21. PMID: 9598798.
    View in: PubMed
  121. Ichinohasama R, Miura I, Shishido T, Matsumoto K, Shimizu Y, Miki T, DeCoteau JF, Kadin ME, Ooya K. Translocation (3;16)(q27;p11) in a patient with diffuse large B-cell lymphoma associated with the BCL-6 gene rearrangement. Cancer Genet Cytogenet. 1998 Jun; 103(2):133-9. PMID: 9614912.
    View in: PubMed
  122. Butmarc JR, Kourea HP, Levi E, Kadin ME. Improved detection of CD5 epitope in formalin-fixed paraffin-embedded sections of benign and neoplastic lymphoid tissues by using biotinylated tyramine enhancement after antigen retrieval. Am J Clin Pathol. 1998 Jun; 109(6):682-8. PMID: 9620024.
    View in: PubMed
  123. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J, Kim DS. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol. 1998 Jun; 22(6):643-55. PMID: 9630171.
    View in: PubMed
  124. Kadin ME, Morris SW. The t(2;5) in human lymphomas. Leuk Lymphoma. 1998 Apr; 29(3-4):249-56. PMID: 9684923.
    View in: PubMed
  125. Dubin DB, Hurowitz JC, Brettler D, Bernhard JD, Kadin ME, Wallace JE, Woda B, Pihan G, Kupper TS, Harrist TJ. Adnexotropic T-cell lymphoma presenting with generalized anhidrosis, progressive alopecia, pruritus, and Sjögren's syndrome. J Am Acad Dermatol. 1998 Mar; 38(3):493-7. PMID: 9520037.
    View in: PubMed
  126. Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998 Jan 15; 91(2):717-23. PMID: 9427731.
    View in: PubMed
  127. Rüdiger T, Jaffe ES, Delsol G, deWolf-Peeters C, Gascoyne RD, Georgii A, Harris NL, Kadin ME, MacLennan KA, Poppema S, Stein H, Weiss LE, Müller-Hermelink HK. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol. 1998; 9 Suppl 5:S31-8. PMID: 9926235.
    View in: PubMed
  128. Ott G, Bastian BC, Katzenberger T, Decoteau JF, Kalla J, Rosenwald A, Weissinger F, Ott MM, Kadin ME, Müller-Hermelink HK. A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation. Br J Haematol. 1998 Jan; 100(1):187-90. PMID: 9450809.
    View in: PubMed
  129. Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M, Younes A. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies. Br J Haematol. 1997 Dec; 99(3):618-24. PMID: 9401075.
    View in: PubMed
  130. Ichinohasama R, DeCoteau JF, Myers J, Kadin ME, Sawai T, Ooya K. Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes. Leukemia. 1997 Nov; 11(11):1891-903. PMID: 9369423.
    View in: PubMed
  131. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997 Oct 15; 100(8):1969-79. PMID: 9329960.
    View in: PubMed
  132. Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PM. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 1997 Sep; 15(9):3060-6. PMID: 9294468.
    View in: PubMed
  133. Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E, Kadin M, Antin J. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes. Biol Blood Marrow Transplant. 1997 Jun; 3(2):98-106. PMID: 9267670.
    View in: PubMed
  134. DeCoteau JF, Knaus PI, Yankelev H, Reis MD, Lowsky R, Lodish HF, Kadin ME. Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1997 May 27; 94(11):5877-81. PMID: 9159168.
    View in: PubMed
  135. Demierre MF, Goldberg LJ, Kadin ME, Koh HK. Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol. 1997 May; 36(5 Pt 1):765-72. PMID: 9146539.
    View in: PubMed
  136. Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong WF, Xu Y, Mak TW, Kadin ME, Minden MD. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood. 1997 Apr 1; 89(7):2276-82. PMID: 9116269.
    View in: PubMed
  137. Butmarc J, Kourea HP, Kadin ME. CD5 immunostaining of lymphoid neoplasms in paraffin sections. Am J Clin Pathol. 1997 Apr; 107(4):496-7; author reply 497. PMID: 9124221.
    View in: PubMed
  138. Kadin ME. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv. 1997; 30:77-86. PMID: 9547987.
    View in: PubMed
  139. Ichinohasama R, Miura I, Takahashi T, Yaginuma Y, Myers J, DeCoteau JF, Yee C, Kadin ME, Mori S, Sawai T. Peripheral CD4+ CD8- gammadelta T cell lymphoma: a case report with multiparameter analyses. Hum Pathol. 1996 Dec; 27(12):1370-7. PMID: 8958314.
    View in: PubMed
  140. Gruss HJ, Kadin ME. Pathophysiology of Hodgkin's disease: functional and molecular aspects. Baillieres Clin Haematol. 1996 Sep; 9(3):417-46. PMID: 8922238.
    View in: PubMed
  141. Wasik MA, Seldin DC, Butmarc JR, Gertz R, Marti R, Maslinski W, Kadin ME. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. Leuk Lymphoma. 1996 Sep; 23(1-2):125-36. PMID: 9021695.
    View in: PubMed
  142. Zhang Q, Nowak I, Vonderheid EC, Rook AH, Kadin ME, Nowell PC, Shaw LM, Wasik MA. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):9148-53. PMID: 8799169.
    View in: PubMed
  143. Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol. 1996 Aug; 149(2):469-81. PMID: 8701986.
    View in: PubMed
  144. Wasik MA, Sackstein R, Novick D, Butmarc JR, Zhang Q, Vonderheid EC, Kadin ME. Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2. Hum Pathol. 1996 Jul; 27(7):738-44. PMID: 8698322.
    View in: PubMed
  145. Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M, Kadin ME, Lodish HF. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol. 1996 Jul; 16(7):3480-9. PMID: 8668164.
    View in: PubMed
  146. Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin ME, Mori S, Sawai T. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report. Cancer. 1996 Jun 15; 77(12):2592-603. PMID: 8640711.
    View in: PubMed
  147. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996 Apr 15; 87(8):3437-41. PMID: 8605362.
    View in: PubMed
  148. Marti RM, Wasik MA, Kadin ME. Constitutive secretion of GM-CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder. Cytokine. 1996 Apr; 8(4):323-9. PMID: 9162223.
    View in: PubMed
  149. Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol. 1996 Apr; 106(4):696-700. PMID: 8618007.
    View in: PubMed
  150. Crowson AN, Magro CM, Kadin ME, Stranc M. Differential expression of the bcl-2 oncogene in human basal cell carcinoma. Hum Pathol. 1996 Apr; 27(4):355-9. PMID: 8617478.
    View in: PubMed
  151. Terenzi A, Bolognesi A, Pasqualucci L, Flenghi L, Pileri S, Stein H, Kadin M, Bigerna B, Polito L, Tazzari PL, Martelli MF, Stirpe F, Falini B. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Br J Haematol. 1996 Mar; 92(4):872-9. PMID: 8616080.
    View in: PubMed
  152. Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol. 1996 Mar; 34(3):470-81. PMID: 8609262.
    View in: PubMed
  153. Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol. 1996 Jan; 132(1):42-7. PMID: 8546482.
    View in: PubMed
  154. Zirbel GM, Gellis SE, Kadin ME, Esterly NB. Lymphomatoid papulosis in children. J Am Acad Dermatol. 1995 Nov; 33(5 Pt 1):741-8. PMID: 7593772.
    View in: PubMed
  155. Agnarsson BA, Kadin ME. Peripheral T-cell lymphomas in children. Semin Diagn Pathol. 1995 Nov; 12(4):314-24. PMID: 8578026.
    View in: PubMed
  156. Resnik KS, Kantor GR, Lessin SR, Kadin ME, Chooback L, Cooper HS, Vonderheid EC. Mycosis fungoides palmaris et plantaris. Arch Dermatol. 1995 Sep; 131(9):1052-6. PMID: 7661607.
    View in: PubMed
  157. DeCoteau JF, Kadin ME. New insights into peripheral T-cell lymphomas. Curr Opin Oncol. 1995 Sep; 7(5):408-14. PMID: 8541384.
    View in: PubMed
  158. Cohen PL, Butmarc J, Kadin ME. Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin. Am J Clin Pathol. 1995 Jul; 104(1):50-3. PMID: 7611181.
    View in: PubMed
  159. Piira T, Perkins SL, Anderson JR, Meadows AT, Chilcote RR, Kadin M, Kjeldsberg CR. Primary mediastinal large cell lymphoma in children: a report from the Childrens Cancer Group. Pediatr Pathol Lab Med. 1995 Jul-Aug; 15(4):561-70. PMID: 8597843.
    View in: PubMed
  160. Tubergen DG, Krailo MD, Meadows AT, Rosenstock J, Kadin M, Morse M, King D, Steinherz PG, Kersey JH. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol. 1995 Jun; 13(6):1368-76. PMID: 7751881.
    View in: PubMed
  161. Pasqualucci L, Wasik M, Teicher BA, Flenghi L, Bolognesi A, Stirpe F, Polito L, Falini B, Kadin ME. Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. Blood. 1995 Apr 15; 85(8):2139-46. PMID: 7718885.
    View in: PubMed
  162. Peters K, Knoll JH, Kadin ME. Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis. Cancer Genet Cytogenet. 1995 Mar; 80(1):13-6. PMID: 7697626.
    View in: PubMed
  163. Kadin ME. Pathology of Hodgkin's disease. Curr Opin Oncol. 1994 Sep; 6(5):456-63. PMID: 7827147.
    View in: PubMed
  164. Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994 Jul; 103(1):34-41. PMID: 8027579.
    View in: PubMed
  165. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheifetz S, George D. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):6002-6. PMID: 8016105.
    View in: PubMed
  166. Kadin ME. Ki-1/CD30+ (anaplastic) large-cell lymphoma: maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol. 1994 May; 12(5):884-7. PMID: 8164037.
    View in: PubMed
  167. Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Am J Pathol. 1994 May; 144(5):1089-97. PMID: 8178932.
    View in: PubMed
  168. Tepler I, Schwartz G, Parker K, Charette J, Kadin ME, Woodworth TG, Schnipper LE. Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy. Cancer. 1994 Feb 15; 73(4):1276-85. PMID: 8313331.
    View in: PubMed
  169. Sioutos N, Kerl H, Murphy SB, Kadin ME. Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol. 1994 Feb; 16(1):2-8. PMID: 8160926.
    View in: PubMed
  170. Finlay JL, Anderson JR, Cecalupo AJ, Hutchinson RJ, Kadin ME, Kjeldsberg CR, Provisor AJ, Woods WG, Meadows AT. Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552. Med Pediatr Oncol. 1994; 23(6):453-63. PMID: 7935170.
    View in: PubMed
  171. Kadin ME. Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol. 1994; 5 Suppl 1:25-30. PMID: 8172812.
    View in: PubMed
  172. Volkenandt M, Bertino JR, Shenoy BV, Koch OM, Kadin ME. Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma. J Dermatol Sci. 1993 Oct; 6(2):121-6. PMID: 8274457.
    View in: PubMed
  173. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993 Sep; 17(9):859-68. PMID: 8394652.
    View in: PubMed
  174. Goldman BD, Oh SK, Davis BE, Kadin ME, Poiesz BJ, Koh HK. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment. Arch Dermatol. 1993 Sep; 129(9):1166-70. PMID: 8363402.
    View in: PubMed
  175. Kadin ME, Vonderheid EC, Weiss LM. Absence of Epstein-Barr viral RNA in lymphomatoid papulosis. J Pathol. 1993 Jun; 170(2):145-8. PMID: 8393923.
    View in: PubMed
  176. Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer. 1993 Mar 15; 71(6):2062-71. PMID: 8443755.
    View in: PubMed
  177. Kadin ME. Lymphomatoid papulosis and associated lymphomas. How are they related? Arch Dermatol. 1993 Mar; 129(3):351-3. PMID: 8447675.
    View in: PubMed
  178. Kadin M, Butmarc J, Elovic A, Wong D. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease. Am J Pathol. 1993 Jan; 142(1):11-6. PMID: 8424449.
    View in: PubMed
  179. Wang HH, Lach L, Kadin ME. Epidemiology of lymphomatoid papulosis. Cancer. 1992 Dec 15; 70(12):2951-7. PMID: 1451079.
    View in: PubMed
  180. Hsu WT, Toporcer MB, Kantor GR, Vonderheid EC, Kadin ME. Cutaneous T-cell lymphoma with porokeratosis-like lesions. J Am Acad Dermatol. 1992 Aug; 27(2 Pt 2):327-30. PMID: 1517498.
    View in: PubMed
  181. Sioutos N, Kadin ME. Perivascular Ki-1 + lesions. Int J Hematol. 1992 Jun; 55(3):275-9. PMID: 1498318.
    View in: PubMed
  182. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med. 1992 Apr 23; 326(17):1115-22. PMID: 1532439.
    View in: PubMed
  183. Olerud JE, Kulin PA, Chew DE, Carlsen RA, Hammar SP, Weir TW, Patterson SD, Bolen JW, Kadin ME, Barker E, et al. Cutaneous T-cell lymphoma. Evaluation of pretreatment skin biopsy specimens by a panel of pathologists. Arch Dermatol. 1992 Apr; 128(4):501-7. PMID: 1580657.
    View in: PubMed
  184. Newcom SR, Tagra KK, Kadin ME. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta. Am J Pathol. 1992 Mar; 140(3):709-18. PMID: 1312308.
    View in: PubMed
  185. Agnarsson BA, Vonderheid EC, Kadin ME. CD8+ cutaneous T-cell lymphoma. Am J Dermatopathol. 1991 Dec; 13(6):628-9. PMID: 1805657.
    View in: PubMed
  186. Kadin ME. Unexpected finding--biologic truth or technical artifact? Hum Pathol. 1991 Oct; 22(10):941-3. PMID: 1842382.
    View in: PubMed
  187. Kadin ME. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease. Semin Dermatol. 1991 Sep; 10(3):164-71. PMID: 1657104.
    View in: PubMed
  188. Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink HK, Van Snick J, et al. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 1991 Sep 1; 78(5):1311-7. PMID: 1908723.
    View in: PubMed
  189. Goldman BD, Bari M, Kantor GR, Kadin ME, Micaily B, Vonderheid EC. Cutaneous multilobated T-cell lymphoma with aggressive course. J Am Acad Dermatol. 1991 Aug; 25(2 Pt 2):345-9. PMID: 1894770.
    View in: PubMed
  190. Kadin ME. Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity? J Clin Oncol. 1991 Apr; 9(4):533-6. PMID: 1648595.
    View in: PubMed
  191. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991 Feb 15; 77(4):799-808. PMID: 1847084.
    View in: PubMed
  192. Vonderheid EC, Kang CA, Kadin M, Bigler RD, Griffin TD, Rogers TJ. Extracorporeal photopheresis in psoriasis vulgaris: clinical and immunologic observations. J Am Acad Dermatol. 1990 Oct; 23(4 Pt 1):703-12. PMID: 2229499.
    View in: PubMed
  193. Su IJ, Wu YC, Chen YC, Hsieh HC, Cheng AL, Wang CH, Kadin ME. Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes. J Am Acad Dermatol. 1990 Oct; 23(4 Pt 1):653-62. PMID: 2229493.
    View in: PubMed
  194. Kadin ME, Said JW. Pathology of malignant lymphomas. Curr Opin Oncol. 1990 Oct; 2(5):822-31. PMID: 1965694.
    View in: PubMed
  195. Kadin ME, Agnarsson BA, Ellingsworth LR, Newcom SR. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol. 1990 Jun; 136(6):1209-14. PMID: 2356855.
    View in: PubMed
  196. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990 Apr; 22(4):569-77. PMID: 2138636.
    View in: PubMed
  197. Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME. Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol. 1990 Apr; 136(4):979-87. PMID: 1691596.
    View in: PubMed
  198. Kadin ME. The spectrum of Ki-1+ cutaneous lymphomas. Curr Probl Dermatol. 1990; 19:132-43. PMID: 2153504.
    View in: PubMed
  199. Kadin ME. The Reed-Sternberg Cell, An Activated T-cell? The Evidence Has Come Full Circle. Leuk Lymphoma. 1990; 2(5):279-86. PMID: 27456917.
    View in: PubMed
  200. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. 1989 Dec; 3(12):866-70. PMID: 2555633.
    View in: PubMed
  201. Su IJ, Kadin ME. Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol. 1989 Sep; 135(3):439-45. PMID: 2789474.
    View in: PubMed
  202. Agnarsson BA, Kadin ME. Host response in lymphomatoid papulosis. Hum Pathol. 1989 Aug; 20(8):747-52. PMID: 2787272.
    View in: PubMed
  203. Agnarsson BA, Loughran TP, Starkebaum G, Kadin ME. The pathology of large granular lymphocyte leukemia. Hum Pathol. 1989 Jul; 20(7):643-51. PMID: 2661408.
    View in: PubMed
  204. Sharpe RJ, Kadin ME, Harmon DC, Imber MJ, Anderson RR. Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides. J Am Acad Dermatol. 1989 Jun; 20(6):1123-4. PMID: 2754062.
    View in: PubMed
  205. Agnarsson BA, Kadin ME. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues. Cancer. 1989 Jun 1; 63(11):2083-7. PMID: 2566368.
    View in: PubMed
  206. Newcom SR, Kadin ME, Ansari AA, Diehl V. L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. J Clin Invest. 1988 Dec; 82(6):1915-21. PMID: 2904450.
    View in: PubMed
  207. Newcom SR, Kadin ME, Phillips C. L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell. Int J Cell Cloning. 1988 Nov; 6(6):417-31. PMID: 3230329.
    View in: PubMed
  208. Su IJ, Balk SP, Kadin ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. Am J Pathol. 1988 Aug; 132(2):192-8. PMID: 2456698.
    View in: PubMed
  209. Newcom SR, Kadin ME, Ansari AA. Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth. Am J Pathol. 1988 Jun; 131(3):569-77. PMID: 2898211.
    View in: PubMed
  210. Agnarsson BA, Kadin ME. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol. 1988 Apr; 12(4):264-74. PMID: 3354752.
    View in: PubMed
  211. Kadin ME, Said J. T-cell lymphomas and leukemias of post-thymic differentiation. Clin Lab Med. 1988 Mar; 8(1):135-50. PMID: 2896086.
    View in: PubMed
  212. Kadin ME, Muramoto L, Said J. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease. Am J Pathol. 1988 Feb; 130(2):345-53. PMID: 2963547.
    View in: PubMed
  213. Aozasa K, Ueda T, Kurata A, Kim CW, Inoue M, Matsuura N, Takeuchi T, Tsujimura T, Kadin ME. Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas. Cancer. 1988 Jan 15; 61(2):309-15. PMID: 3334966.
    View in: PubMed
  214. Agnarsson BA, Kadin ME. An unusual B-cell lymphoma simulating hairy cell leukemia. Am J Clin Pathol. 1987 Dec; 88(6):752-9. PMID: 3500633.
    View in: PubMed
  215. Muramoto LM, Kadin ME. Improved detection of lymphoid cell surface antigens in tissues fixed in periodate-lysine-paraformaldehyde (PLP). Am J Clin Pathol. 1987 Nov; 88(5):589-95. PMID: 2823597.
    View in: PubMed
  216. Kadin ME. Histogenesis of Hodgkin's disease: possible insights from a comparison with lymphomatoid papulosis. Hum Pathol. 1987 Nov; 18(11):1085-8. PMID: 3500105.
    View in: PubMed
  217. Loughran TP, Starkebaum G, Clark E, Wallace P, Kadin ME. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol. 1987 Oct; 67(2):135-40. PMID: 3479187.
    View in: PubMed
  218. Starkebaum G, Loughran TP, Kalyanaraman VS, Kadin ME, Kidd PG, Singer JW, Ruscetti FW. Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet. 1987 Mar 14; 1(8533):596-9. PMID: 2881134.
    View in: PubMed
  219. Ree HJ, Kadin ME. The usefulness of peanut agglutinin for the detection of histiocytosis-X and interdigitating reticulum cells. Hum Pathol. 1987 Mar; 18(3):309-10. PMID: 3493200.
    View in: PubMed
  220. Head DR, Kjeldsberg CR, Kadin ME, Pick T, Bybee B, Longbotham J, Shumski E. Childhood T-cell malignancy resembling adult T-cell leukemia/lymphoma. Hematol Pathol. 1987; 1(1):15-25. PMID: 3504428.
    View in: PubMed
  221. Kadin ME. Cutaneous Ki-1 lymphoma: pathology, immunology and clinical characteristics. Princess Takamatsu Symp. 1987; 18:187-95. PMID: 3506541.
    View in: PubMed
  222. Kadin ME, Vonderheid EC, Sako D, Clayton LK, Olbricht S. Clonal composition of T cells in lymphomatoid papulosis. Am J Pathol. 1987 Jan; 126(1):13-7. PMID: 3544850.
    View in: PubMed
  223. Kadin ME. Characteristic immunologic profile of large atypical cells in lymphomatoid papulosis. Possible implications for histogenesis and relationship to other diseases. Arch Dermatol. 1986 Dec; 122(12):1388-90. PMID: 3024585.
    View in: PubMed
  224. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol. 1986 Dec; 23(4):363-71. PMID: 3098093.
    View in: PubMed
  225. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986 Nov; 68(5):1042-9. PMID: 3490284.
    View in: PubMed
  226. Abkowitz JL, Kadin ME, Powell JS, Adamson JW. Pure red cell aplasia: lymphocyte inhibition of erythropoiesis. Br J Haematol. 1986 May; 63(1):59-67. PMID: 3085703.
    View in: PubMed
  227. Su IJ, Shih LY, Kadin ME, Dun P, Hsu SM. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-associated adult T-cell lymphoma/leukemia. Am J Clin Pathol. 1985 Dec; 84(6):715-23. PMID: 3000162.
    View in: PubMed
  228. Kadin ME. Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet. 1985 Oct 19; 2(8460):864-5. PMID: 2413323.
    View in: PubMed
  229. Ree HJ, Kadin ME. Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease. Cancer. 1985 Jul 15; 56(2):333-8. PMID: 2408733.
    View in: PubMed
  230. Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M. Immunopathology of cutaneous T-cell lymphomas. Am J Pathol. 1985 Jun; 119(3):436-47. PMID: 3893149.
    View in: PubMed
  231. Kadin M, Nasu K, Sako D, Said J, Vonderheid E. Lymphomatoid papulosis. A cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol. 1985 May; 119(2):315-25. PMID: 3158209.
    View in: PubMed
  232. Bolen JW, Kadin ME. Cutaneous T-cell lymphoma with Reed-Sternberg cells: a light microscopic, immunocytochemical, and ultrastructural study. Ultrastruct Pathol. 1985; 9(3-4):225-31. PMID: 3879027.
    View in: PubMed
  233. Foucar K, Carroll TJ, Tannous R, Peterson L, Goeken JA, Binion S, Gajl-Peczalska J, Kadin ME, Yokoyama WM. Nonendemic adult T-cell leukemia/lymphoma in the United States: report of two cases and review of the literature. Am J Clin Pathol. 1985 Jan; 83(1):18-26. PMID: 2981466.
    View in: PubMed
  234. Mori N, Tsunoda R, Kojima M, Andres T, Kadin ME. Ultrastructural localization of immunoglobulins in hairy cell leukemia. Hum Pathol. 1984 Nov; 15(11):1042-7. PMID: 6436166.
    View in: PubMed
  235. Kadin ME, Nasu K, Sako D, Su IJ. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia. Cancer Res. 1984 Aug; 44(8):3383-7. PMID: 6611200.
    View in: PubMed
  236. Burstein SA, Malpass TW, Yee E, Kadin M, Brigden M, Adamson JW, Harker LA. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Br J Haematol. 1984 Jul; 57(3):383-92. PMID: 6743563.
    View in: PubMed
  237. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States--Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol. 1983 Sep; 14(9):745-72. PMID: 6350154.
    View in: PubMed
  238. Sullivan KM, Neiman PE, Kadin ME, Dahlberg S, Farewell VT, Rudolph RH, Bagley CM, Appelbaum FR, Thomas ED. Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients. Blood. 1983 Jul; 62(1):51-61. PMID: 6344932.
    View in: PubMed
  239. Andres TL, Kadin ME. Immunologic markers in the differential diagnosis of small round cell tumors from lymphocytic lymphoma and leukemia. Am J Clin Pathol. 1983 May; 79(5):546-52. PMID: 6188365.
    View in: PubMed
  240. Kadin ME, Kamoun M. Nonendemic adult T-cell leukemia/lymphoma. Hum Pathol. 1982 Aug; 13(8):691-3. PMID: 6980817.
    View in: PubMed
  241. Kadin ME. Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep. 1982 Apr; 66(4):601-8. PMID: 6951633.
    View in: PubMed
  242. Kim H, Pangalis GA, Payne BC, Kadin ME, Rappaport H. Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique. Am J Pathol. 1982 Feb; 106(2):204-23. PMID: 6950665.
    View in: PubMed
  243. Kadin ME. T gamma cells: a missing link between malignant histiocytosis and T cell leukemia-lymphoma? Hum Pathol. 1981 Sep; 12(9):771-2. PMID: 6975747.
    View in: PubMed
  244. Kadin ME, Kamoun M, Lamberg J. Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med. 1981 Mar 12; 304(11):648-53. PMID: 6969851.
    View in: PubMed
  245. Poore TE, Barrett SG, Kadin ME, Bainton DF. Ultrastructural localization of acid phosphatase in rosetted T and B lymphocytes of normal human blood. Am J Pathol. 1981 Jan; 102(1):72-83. PMID: 6970526.
    View in: PubMed
  246. Kadin ME. Ia-like (HLA-DR) antigens in the diagnosis of lymphoma and undifferentiated tumors. Arch Pathol Lab Med. 1980 Oct; 104(10):503-508. PMID: 6998408.
    View in: PubMed
  247. Kadin ME. A reappraisal of the Reed-Sternberg cell: a commentary. Blood Cells. 1980; 6(3):525-32. PMID: 6994843.
    View in: PubMed
  248. Sybert VP, Setran KN, Kadin ME. Lymphocyte capping in carriers of Duchenne muscular dystrophy. N Engl J Med. 1979 Sep 27; 301(13):724-5. PMID: 481471.
    View in: PubMed
  249. Newcom SR, Kadin ME. T-cell leukemia with thymic involution. Cancer. 1979 Feb; 43(2):622-6. PMID: 311242.
    View in: PubMed
  250. Kadin ME, Stites DP, Levy R, Warnke R. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1978 Nov 30; 299(22):1208-14. PMID: 101841.
    View in: PubMed
  251. Kadin ME, Billing RJ. B lymphocyte antigens in the differential diagnosis of human neoplasia. Blood. 1978 May; 51(5):813-23. PMID: 346089.
    View in: PubMed
  252. Kadin M, Billing RJ. Immunofluorescent method for positive identification of null-cell type acute lymphocytic leukemias: use of heterologous antiserum. Blood. 1977 Nov; 50(5):771-82. PMID: 332257.
    View in: PubMed
  253. Barrett SG, Schwade JG, Ranken R, Kadin ME. Lymphoblasts with both T and B markers in childhood leukemia and lymphoma. Blood. 1977 Jul; 50(1):71-9. PMID: 326316.
    View in: PubMed
  254. Perkins HA, McIlroy M, Swanson J, Kadin M. Transient LW-negative red blood cells and anti-LW in a patient with Hodgkin's disease. Vox Sang. 1977; 33(5):299-303. PMID: 411256.
    View in: PubMed
  255. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr; 31(4):806-23. PMID: 4574662.
    View in: PubMed
  256. Kadin ME, Asbury AK. Long term cultures of Hodgkin's tissue. A morphologic and radioautographic study. Lab Invest. 1973 Feb; 28(2):181-4. PMID: 4687527.
    View in: PubMed
  257. Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF. Non-Hodgkin's lymphomas. II. Single agent chemotherapy. Cancer. 1972 Jul; 30(1):31-8. PMID: 4557278.
    View in: PubMed
  258. Kadin ME, Glatstein E, Dorfman RF. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer. 1971 Jun; 27(6):1277-94. PMID: 5088206.
    View in: PubMed
  259. Kadin ME, Donaldson SS, Dorfman RF. Isolated granulomas in Hodgkin's disease. N Engl J Med. 1970 Oct 15; 283(16):859-61. PMID: 5458036.
    View in: PubMed
Marshall's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department